Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
68.56
-2.55 (-3.59%)
At close: May 1, 2026, 4:00 PM EDT
68.73
+0.17 (0.25%)
After-hours: May 1, 2026, 7:58 PM EDT

BridgeBio Pharma Revenue

In the year 2025, BridgeBio Pharma had annual revenue of $502.08M with 126.26% growth. BridgeBio Pharma had revenue of $154.18M in the quarter ending December 31, 2025, with 2,521.18% growth.

Revenue (ttm)
$502.08M
Revenue Growth
+126.26%
P/S Ratio
26.74
Revenue / Employee
$598,422
Employees
839
Market Cap
13.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025502.08M280.17M126.26%
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 201940.56M--
Dec 31, 2018---
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jazz Pharmaceuticals4.27B
Genmab3.72B
BioMarin Pharmaceutical3.22B
Exelixis2.32B
Moderna2.23B
Arrowhead Pharmaceuticals1.09B
Ionis Pharmaceuticals1.06B
Madrigal Pharmaceuticals958.40M
Revenue Rankings

BBIO News

More News